Freshfields Bruckhaus Deringer advised Affimed N.V. (Nasdaq: AFMD) on the deal.Affimed N.V. announced its strategic collaboration with Artiva Biotherapeutics Inc. (‘Artiva‘), likewise an immuno-oncology company, to jointly develop,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
